World's Best Scientists 2026 revealed!
Jules L. Dienstag

Jules L. Dienstag

D-Index & Metrics

Microbiology

D-Index
97
Citations
49201
World Ranking
468
National Ranking
216

Medicine

D-Index
105
Citations
54361
World Ranking
6680
National Ranking
3529

Jules L. Dienstag publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jules L. Dienstag sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 289 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jules L. Dienstag D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jules L. Dienstag sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 97 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Jules L. Dienstag is affiliated with Harvard University in the United States and specializes in the field of Medicine, with significant contributions to subfields such as Public Health, Environmental and Occupational Health, Epidemiology, Family Practice, Psychiatry and Mental Health, and Gender Studies.

Their research focuses on a range of topics including Innovations in Medical Education, Clinical Reasoning and Diagnostic Skills, Empathy and Medical Education, Medical Education and Admissions, Diversity and Career in Medicine, Hepatitis C virus research, and Liver Disease Diagnosis and Treatment.

Jules L. Dienstag has published multiple papers in prominent academic venues. Significant recent papers include:

  • "Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation" (2020), Proceedings of the National Academy of Sciences
  • "The Harvard Medical School Pathways Curriculum: Reimagining Developmentally Appropriate Medical Education for Contemporary Learners" (2020), Academic Medicine
  • "Do Professionalism Lapses in Medical School Predict Problems in Residency and Clinical Practice?" (2020), Academic Medicine
  • "The Harvard Medical School Pathways curriculum: A comprehensive curricular evaluation" (2022), Medical Teacher
  • "A snapshot of underrepresented physicians 15 years after medical school" (2020), Advances in Health Sciences Education

Their frequent co-authors highlight collaborative work with Edward Krupat, Raymond T. Chung, Richard M. Schwartzstein, John L. Dalrymple, and Sara B. Fazio.

Jules L. Dienstag's research has appeared in several key publication venues, with multiple contributions to:

  • Hepatology
  • Academic Medicine
  • Proceedings of the National Academy of Sciences
  • Medical Teacher
  • Advances in Health Sciences Education

In recognition of their work, Jules L. Dienstag was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2014.

Best Publications

  • An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

    G. Kuo;Q.-L. Choo;H.J. Alter;G.L. Gitnick

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

    Davis Gl;Balart La;Schiff Er;Lindsay K

  • Viral Hepatitis and Liver Disease

    Girish N. Vyas;Jules Dienstag;Jay H. Hoofnagle

  • Lamivudine as initial treatment for chronic hepatitis B in the United States.

    Jules L. Dienstag;Eugene R. Schiff;Teresa L. Wright;Robert P. Perrillo

  • An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

    Unknown

  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

    John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard

  • Hepatitis B Virus Infection

    Jules L. Dienstag

  • A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

    Jules L. Dienstag;Robert P. Perrillo;Eugene R. Schiff;Maria Bartholomew

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

    Robert P. Perrillo;Eugene R. Schiff;Gary L. Davis;Henry C. Bodenheimer

  • Histological outcome during long-term lamivudine therapy.

    Jules L. Dienstag;Robert D. Goldin;E.Jenny Heathcote;H.W.L. Hann

  • Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

    Ching Lung Lai;Jules Dienstag;Eugene Schiff;Nancy W.Y. Leung

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

    Anna S. Lok;Richard K. Sterling;James E. Everhart;Elizabeth C. Wright

  • Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features

    Jules L. Dienstag

  • Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C

    Timothy R. Morgan;Timothy R. Morgan;Marc G. Ghany;Hae Young Kim;Kristin K. Snow

  • Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.

    M J Koziel;D Dudley;J T Wong;J Dienstag

  • Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region

    Lieven J. Stuyver;Stephen A. Locarnini;Anna Lok;Douglas D. Richman

  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

    Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay

Frequent Co-Authors

Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Marc G. Ghany
Marc G. Ghany National Institutes of Health
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
Chihiro Morishima
Chihiro Morishima University of Washington
Gregory T. Everson
Gregory T. Everson University of Colorado Denver
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Raymond T. Chung
Raymond T. Chung Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, including health-related fields that combine biology with data management and coding. Many students explore areas like medical billing and coding, where understanding biological data is crucial. For those interested in quick entry into the healthcare administration sector, the quickest medical billing and coding certificate online programs provide streamlined pathways to certification.

Another promising route is health information management, which blends healthcare knowledge with information systems. Earning a best online health information management degree cahiim accredited can enhance your qualifications and open career opportunities in managing patient records and healthcare data efficiently.

Professionals in these fields often pursue certifications that impact their earning potential. For instance, understanding how a certified professional coder salary correlates with certification status can guide career planning.

Moreover, individuals with a background in microbiology and health data can advance to roles such as health information managers. Learning about the health information management bachelor degree salary helps assess the long-term benefits of such career pathways.

Best Scientists Citing Jules L. Dienstag

Trending Scientists

Recently Published Articles